MedTrace Logo

Utility and Procedural Feasibility of REBOA Operationalized for Non-Trauma Application (UP-FRONT)

NCT05236920 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2023-03-20

No results posted yet for this study

Summary

Single center randomized-controlled trial in out-of-hospital cardiac arrest (OHCA) patients. This study will investigate the feasibility and utility of the Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) procedure using a REBOA catheter device in patients who have experienced an OHCA and have not regained return of spontaneous circulation (ROSC).

Conditions

  • Cardiac Arrest, Out-Of-Hospital
  • Ventricular Fibrillation
  • Ventricular Tachycardia

Interventions

DEVICE

Resuscitative Endovascular balloon occlusion of the aorta using a REBOA catheter device

In-hospital use of a REBOA catheter device during advanced cardiac life support

Sponsors & Collaborators

  • University of Alabama at Birmingham

    lead OTHER

Principal Investigators

  • Michael C Kurz, MD · Professor and Vice-Chair for Research, Department of Emergency Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-01
Primary Completion
2022-10-31
Completion
2022-10-31
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05236920 on ClinicalTrials.gov